COVID-19 Impact on Global Crohn’s Disease Diagnostic and Therapeutic Market Size, Status and Forecast 2020-2026
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Crohn’s Disease Diagnostic and Therapeutic market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Crohn’s Disease Diagnostic and Therapeutic industry.
Based on our recent survey, we have several different scenarios about the Crohn’s Disease Diagnostic and Therapeutic YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Crohn’s Disease Diagnostic and Therapeutic will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn’s Disease Diagnostic and Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn’s Disease Diagnostic and Therapeutic market in terms of revenue.
Players, stakeholders, and other participants in the global Crohn’s Disease Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Crohn’s Disease Diagnostic and Therapeutic market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Crohn’s Disease Diagnostic and Therapeutic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn’s Disease Diagnostic and Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn’s Disease Diagnostic and Therapeutic market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Crohn’s Disease Diagnostic and Therapeutic market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Crohn’s Disease Diagnostic and Therapeutic industry.
Based on our recent survey, we have several different scenarios about the Crohn’s Disease Diagnostic and Therapeutic YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Crohn’s Disease Diagnostic and Therapeutic will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn’s Disease Diagnostic and Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn’s Disease Diagnostic and Therapeutic market in terms of revenue.
Players, stakeholders, and other participants in the global Crohn’s Disease Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Crohn’s Disease Diagnostic and Therapeutic market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Crohn’s Disease Diagnostic and Therapeutic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn’s Disease Diagnostic and Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn’s Disease Diagnostic and Therapeutic market.
The following players are covered in this report:
- Abbvie
- Celgene
- Genetech
- Johnson & Johnson
- Pfizer
- Prometheus Laboratories
- Salix Pharmaceuticals
- Takeda Pharmaceutical
- Diagnostics
- Treatment
- Hospital
- Medical Research Institute
- Other
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
1.4 Market Analysis by Type
1.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnostics
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Crohn’s Disease Diagnostic and Therapeutic Industry Impact
1.6.1 How the Covid-19 is Affecting the Crohn’s Disease Diagnostic and Therapeutic Industry
1.6.1.1 Crohn’s Disease Diagnostic and Therapeutic Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Crohn’s Disease Diagnostic and Therapeutic Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Crohn’s Disease Diagnostic and Therapeutic Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2015-2026)
2.2 Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Regions
2.2.1 Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Crohn’s Disease Diagnostic and Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Crohn’s Disease Diagnostic and Therapeutic Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Market Size
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2019
3.3 Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Area Served
3.4 Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
3.5 Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2021-2026)
5 CROHN’S DISEASE DIAGNOSTIC AND THERAPEUTIC BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
6.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in North America (2019-2020)
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
7.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
8 CHINA
8.1 China Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
8.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in China (2019-2020)
8.3 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
8.4 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
9.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
9.4 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
10.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
11 INDIA
11.1 India Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
11.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in India (2019-2020)
11.3 India Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
11.4 India Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
12.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview and Its Total Revenue
13.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Introduction
13.1.4 Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Celgene
13.2.1 Celgene Company Details
13.2.2 Celgene Business Overview and Its Total Revenue
13.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Introduction
13.2.4 Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.2.5 Celgene Recent Development
13.3 Genetech
13.3.1 Genetech Company Details
13.3.2 Genetech Business Overview and Its Total Revenue
13.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
13.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.3.5 Genetech Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
13.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
13.4.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
13.5.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Prometheus Laboratories
13.6.1 Prometheus Laboratories Company Details
13.6.2 Prometheus Laboratories Business Overview and Its Total Revenue
13.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
13.6.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.6.5 Prometheus Laboratories Recent Development
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Details
13.7.2 Salix Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
13.7.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.7.5 Salix Pharmaceuticals Recent Development
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical Company Details
13.8.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
13.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
13.8.4 Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.8.5 Takeda Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
1.4 Market Analysis by Type
1.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnostics
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Crohn’s Disease Diagnostic and Therapeutic Industry Impact
1.6.1 How the Covid-19 is Affecting the Crohn’s Disease Diagnostic and Therapeutic Industry
1.6.1.1 Crohn’s Disease Diagnostic and Therapeutic Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Crohn’s Disease Diagnostic and Therapeutic Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Crohn’s Disease Diagnostic and Therapeutic Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2015-2026)
2.2 Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Regions
2.2.1 Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Crohn’s Disease Diagnostic and Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Crohn’s Disease Diagnostic and Therapeutic Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Market Size
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2019
3.3 Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Area Served
3.4 Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
3.5 Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2021-2026)
5 CROHN’S DISEASE DIAGNOSTIC AND THERAPEUTIC BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
6.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in North America (2019-2020)
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
7.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
8 CHINA
8.1 China Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
8.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in China (2019-2020)
8.3 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
8.4 China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
9.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
9.4 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
10.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
11 INDIA
11.1 India Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
11.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in India (2019-2020)
11.3 India Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
11.4 India Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size (2015-2020)
12.2 Crohn’s Disease Diagnostic and Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview and Its Total Revenue
13.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Introduction
13.1.4 Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Celgene
13.2.1 Celgene Company Details
13.2.2 Celgene Business Overview and Its Total Revenue
13.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Introduction
13.2.4 Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.2.5 Celgene Recent Development
13.3 Genetech
13.3.1 Genetech Company Details
13.3.2 Genetech Business Overview and Its Total Revenue
13.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
13.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.3.5 Genetech Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
13.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
13.4.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
13.5.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Prometheus Laboratories
13.6.1 Prometheus Laboratories Company Details
13.6.2 Prometheus Laboratories Business Overview and Its Total Revenue
13.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
13.6.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.6.5 Prometheus Laboratories Recent Development
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Details
13.7.2 Salix Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
13.7.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.7.5 Salix Pharmaceuticals Recent Development
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical Company Details
13.8.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
13.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
13.8.4 Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
13.8.5 Takeda Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Crohn’s Disease Diagnostic and Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
Table 3. Ranking of Global Top Crohn’s Disease Diagnostic and Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnostics
Table 6. Key Players of Treatment
Table 7. COVID-19 Impact Global Market: (Four Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Crohn’s Disease Diagnostic and Therapeutic Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Crohn’s Disease Diagnostic and Therapeutic Players to Combat Covid-19 Impact
Table 12. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2015-2020)
Table 16. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Crohn’s Disease Diagnostic and Therapeutic Market Growth Strategy
Table 22. Main Points Interviewed from Key Crohn’s Disease Diagnostic and Therapeutic Players
Table 23. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 24. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players (2015-2020)
Table 25. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2019)
Table 26. Global Crohn’s Disease Diagnostic and Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
Table 29. Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 32. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Share by Type (2015-2020)
Table 33. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2021-2026)
Table 34. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Share by Application (2015-2020)
Table 35. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 36. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Share by Application (2021-2026)
Table 37. North America Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 39. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 40. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 41. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 42. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 43. Europe Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 45. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 47. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 49. China Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 50. China Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 51. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 52. China Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 53. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 54. China Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 55. Japan Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 57. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 59. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 63. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 65. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 67. India Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 68. India Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 69. India Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 70. India Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 71. India Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 72. India Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 75. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 77. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 79. Abbvie Company Details
Table 80. Abbvie Business Overview
Table 81. Abbvie Product
Table 82. Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 83. Abbvie Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Product
Table 87. Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 88. Celgene Recent Development
Table 89. Genetech Company Details
Table 90. Genetech Business Overview
Table 91. Genetech Product
Table 92. Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 93. Genetech Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 98. Johnson & Johnson Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Product
Table 102. Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 103. Pfizer Recent Development
Table 104. Prometheus Laboratories Company Details
Table 105. Prometheus Laboratories Business Overview
Table 106. Prometheus Laboratories Product
Table 107. Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 108. Prometheus Laboratories Recent Development
Table 109. Salix Pharmaceuticals Company Details
Table 110. Salix Pharmaceuticals Business Overview
Table 111. Salix Pharmaceuticals Product
Table 112. Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 113. Salix Pharmaceuticals Recent Development
Table 114. Takeda Pharmaceutical Business Overview
Table 115. Takeda Pharmaceutical Product
Table 116. Takeda Pharmaceutical Company Details
Table 117. Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 118. Takeda Pharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 1. Crohn’s Disease Diagnostic and Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
Table 3. Ranking of Global Top Crohn’s Disease Diagnostic and Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnostics
Table 6. Key Players of Treatment
Table 7. COVID-19 Impact Global Market: (Four Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Crohn’s Disease Diagnostic and Therapeutic Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Crohn’s Disease Diagnostic and Therapeutic Players to Combat Covid-19 Impact
Table 12. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2015-2020)
Table 16. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Crohn’s Disease Diagnostic and Therapeutic Market Growth Strategy
Table 22. Main Points Interviewed from Key Crohn’s Disease Diagnostic and Therapeutic Players
Table 23. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 24. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players (2015-2020)
Table 25. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2019)
Table 26. Global Crohn’s Disease Diagnostic and Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Crohn’s Disease Diagnostic and Therapeutic Product Solution and Service
Table 29. Date of Enter into Crohn’s Disease Diagnostic and Therapeutic Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 32. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Share by Type (2015-2020)
Table 33. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2021-2026)
Table 34. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Share by Application (2015-2020)
Table 35. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 36. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Share by Application (2021-2026)
Table 37. North America Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 39. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 40. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 41. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 42. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 43. Europe Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 45. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 47. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 49. China Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 50. China Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 51. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 52. China Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 53. China Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 54. China Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 55. Japan Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 57. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 59. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 63. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 65. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 67. India Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 68. India Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 69. India Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 70. India Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 71. India Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 72. India Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Crohn’s Disease Diagnostic and Therapeutic Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Crohn’s Disease Diagnostic and Therapeutic Market Share (2019-2020)
Table 75. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Share by Type (2015-2020)
Table 77. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Share by Application (2015-2020)
Table 79. Abbvie Company Details
Table 80. Abbvie Business Overview
Table 81. Abbvie Product
Table 82. Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 83. Abbvie Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Product
Table 87. Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 88. Celgene Recent Development
Table 89. Genetech Company Details
Table 90. Genetech Business Overview
Table 91. Genetech Product
Table 92. Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 93. Genetech Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 98. Johnson & Johnson Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Product
Table 102. Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 103. Pfizer Recent Development
Table 104. Prometheus Laboratories Company Details
Table 105. Prometheus Laboratories Business Overview
Table 106. Prometheus Laboratories Product
Table 107. Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 108. Prometheus Laboratories Recent Development
Table 109. Salix Pharmaceuticals Company Details
Table 110. Salix Pharmaceuticals Business Overview
Table 111. Salix Pharmaceuticals Product
Table 112. Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 113. Salix Pharmaceuticals Recent Development
Table 114. Takeda Pharmaceutical Business Overview
Table 115. Takeda Pharmaceutical Product
Table 116. Takeda Pharmaceutical Company Details
Table 117. Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020) (Million US$)
Table 118. Takeda Pharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Diagnostics Features
Figure 3. Treatment Features
Figure 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Medical Research Institute Case Studies
Figure 7. Other Case Studies
Figure 8. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
Figure 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions: 2020 VS 2026
Figure 11. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players in 2019
Figure 14. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2019
Figure 16. North America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbvie Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 25. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Celgene Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 27. Genetech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Genetech Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 33. Prometheus Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Prometheus Laboratories Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 35. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 37. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Takeda Pharmaceutical Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Figure 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Diagnostics Features
Figure 3. Treatment Features
Figure 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Medical Research Institute Case Studies
Figure 7. Other Case Studies
Figure 8. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
Figure 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions: 2020 VS 2026
Figure 11. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players in 2019
Figure 14. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2019
Figure 16. North America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbvie Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 25. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Celgene Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 27. Genetech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Genetech Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 33. Prometheus Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Prometheus Laboratories Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 35. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 37. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Takeda Pharmaceutical Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
